Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.

Saved in:
Bibliographic Details
Title: Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Authors: Krishnan T; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Safro M; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Furlanetto DM; Department of Radiology, Department of Surgical Oncology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Gill S; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Solar Vasconcelos JP; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Stuart HC; Department of Radiology, Department of Surgical Oncology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Martineau P; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Loree JM; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada.
Source: Journal of neuroendocrinology [J Neuroendocrinol] 2024 Jan; Vol. 36 (1), pp. e13360. Date of Electronic Publication: 2023 Dec 13.
Publication Type: Journal Article
Journal Info: Publisher: Wiley & Sons Country of Publication: United States NLM ID: 8913461 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2826 (Electronic) Linking ISSN: 09538194 NLM ISO Abbreviation: J Neuroendocrinol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2826
DOI:10.1111/jne.13360